06c1c8ee-6564-46fe-9989-dbf4fbf086fe_1531776 - ... File

By filing a petition shortly before a generic's expected approval, a manufacturer can force the FDA to spend time and resources reviewing the claim.

Under FDA regulations, any individual or entity can petition the agency to take (or refrain from taking) a specific administrative action. In the context of pharmaceuticals, these are often used to raise concerns about the safety or bioequivalence of a pending generic drug application (ANDA). 2. The "Sham" Petition Concern 06C1C8EE-6564-46FE-9989-DBF4FBF086FE_1531776 - ...

The Federal Trade Commission (FTC) continues to monitor this area for antitrust violations. While many petitions raise legitimate scientific concerns, the debate remains: how to balance the right to petition the government with the need for competitive, affordable healthcare markets. By filing a petition shortly before a generic's

Even if the petition is ultimately denied, the delay can preserve the brand's monopoly for months, translating into significant additional revenue. 3. Legislative Countermeasures Even if the petition is ultimately denied, the

The core issue discussed in the SSRN study (ID 1531776) is whether brand-name manufacturers use these filings strategically.

In the complex world of pharmaceutical regulation, the serves as a vital public safety valve. However, as explored in the paper associated with your identifier, this mechanism has also been scrutinized as a potential tool for "gaming" the system to delay the market entry of lower-priced generic drugs. 1. What is a Citizen Petition?

Prevents the FDA from delaying the approval of a generic drug unless a delay is necessary to protect public health.